Select Medical Holdings Corporation (NYSE:SEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Select Medical Holdings Corporation (NYSE:SEM - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $26.00.

A number of equities research analysts have recently weighed in on SEM shares. Royal Bank Of Canada lowered their target price on Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research note on Wednesday, May 7th. Mizuho started coverage on Select Medical in a research note on Wednesday, April 16th. They issued an "outperform" rating and a $25.00 target price for the company.

Get Our Latest Stock Analysis on Select Medical

Insider Activity at Select Medical

In other Select Medical news, CEO David S. Chernow sold 225,000 shares of the company's stock in a transaction that occurred on Monday, April 28th. The stock was sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the transaction, the chief executive officer now owns 714,516 shares in the company, valued at approximately $12,861,288. This represents a 23.95% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Parvinderjit S. Khanuja bought 21,000 shares of Select Medical stock in a transaction on Monday, May 5th. The shares were purchased at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the acquisition, the director now directly owns 65,089 shares in the company, valued at approximately $977,636.78. This trade represents a 47.63% increase in their position. The disclosure for this purchase can be found here. 11.60% of the stock is owned by company insiders.

Institutional Trading of Select Medical

A number of hedge funds have recently made changes to their positions in the stock. Voya Investment Management LLC boosted its position in shares of Select Medical by 48.7% in the 1st quarter. Voya Investment Management LLC now owns 1,507,349 shares of the health services provider's stock worth $25,173,000 after purchasing an additional 493,983 shares in the last quarter. Strs Ohio bought a new stake in shares of Select Medical in the 1st quarter worth approximately $773,000. Intech Investment Management LLC boosted its position in shares of Select Medical by 21.2% in the 1st quarter. Intech Investment Management LLC now owns 176,721 shares of the health services provider's stock worth $2,951,000 after purchasing an additional 30,892 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of Select Medical in the 1st quarter worth approximately $4,635,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Select Medical by 3.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 323,968 shares of the health services provider's stock worth $5,410,000 after purchasing an additional 10,329 shares in the last quarter. 89.48% of the stock is owned by institutional investors.

Select Medical Stock Up 1.7%

Shares of NYSE:SEM opened at $15.27 on Monday. Select Medical has a 52-week low of $14.03 and a 52-week high of $40.98. The firm has a fifty day moving average of $15.39 and a 200 day moving average of $17.19. The firm has a market capitalization of $1.96 billion, a PE ratio of 11.39, a price-to-earnings-growth ratio of 0.81 and a beta of 1.34. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.16 and a current ratio of 1.16.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.01). Select Medical had a return on equity of 11.04% and a net margin of 2.81%. The company had revenue of $1.35 billion during the quarter, compared to analysts' expectations of $1.40 billion. During the same quarter in the prior year, the firm posted $0.75 EPS. The firm's quarterly revenue was down 24.4% on a year-over-year basis. As a group, research analysts anticipate that Select Medical will post 1.17 EPS for the current fiscal year.

Select Medical declared that its Board of Directors has initiated a share repurchase plan on Thursday, May 1st that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to reacquire up to 42.6% of its stock through open market purchases. Stock buyback plans are often an indication that the company's board of directors believes its shares are undervalued.

Select Medical Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a dividend of $0.0625 per share. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a yield of 1.64%. Select Medical's dividend payout ratio is presently 18.66%.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

• Five stocks we like better than Select Medical
• Stock Analyst Ratings and Canadian Analyst Ratings
• AutoNation: Growth Engines Make It an Undervalued Stock
• What Are Dividend Achievers? An Introduction
• Snowflake Hits 52-Week High—Options Traders Bet on Further Rally
• What does consumer price index measure?
• 3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here